Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$113.95 +0.01 (+0.01%)
At close: Nov 10, 2026 · 4:00 PM EST

Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2026)

Updated

Rhythm Pharmaceuticals' Depreciation & Amortization (CF) came in at $315,000 for Q3 2021, up 83.1% from $172,000 a year earlier but down 0.6% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2021, Rhythm Pharmaceuticals reported Depreciation & Amortization (CF) of $1.01 million, up 43.8% year-over-year; for FY2020, it was $690,000, down 17.3% from FY2019.

  • Depreciation & Amortization (CF) carries a four-year compound annual growth rate of 48.0% (FY2016 to FY2020).
  • Going back by year, Depreciation & Amortization (CF) was $834,000 in FY2019 (+88.7%), $442,000 in FY2018 (+98.2%), $223,000 in FY2017 (+54.9%) and $144,000 in FY2016.
  • The five-year range for quarterly Depreciation & Amortization (CF) is $54,000 (Q1 2017) to $317,000 (Q2 2021).
  • Year-over-year, Depreciation & Amortization (CF) has increased for three consecutive quarters, with growth averaging 13.9% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q1 2019 (growth of 301.6%), and the weakest in Q1 2020 (a decline of 31.8%).
  • Business Quant data shows RYTM's Depreciation & Amortization (CF) at $317,000 (Q2 2021), $201,000 (Q1 2021) and $178,000 (Q4 2020) in the three quarters before Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 545.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.12 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.61 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.58 Bn
10 Rhythm Pharmaceuticals 7.90 Bn 6.52 Bn 79.96 Mn 248,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 248,000.00
Jun 30, 2026 251,000.00
Mar 31, 2026 252,000.00
Dec 31, 2025 272,000.00
Sep 30, 2025 304,000.00
Jun 30, 2025 379,000.00
Mar 31, 2025 383,000.00
Dec 31, 2024 383,000.00
Sep 30, 2024 385,000.00
Jun 30, 2024 390,000.00
Mar 31, 2024 405,000.00
Dec 31, 2023 417,000.00
Sep 30, 2023 442,000.00
Jun 30, 2023 442,000.00
Mar 31, 2023 457,000.00
Dec 31, 2022 442,000.00
Sep 30, 2022 442,000.00
Jun 30, 2022 438,000.00
Mar 31, 2022 350,000.00
Dec 31, 2021 325,000.00
API Access

Rhythm Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RYTM&period=max&api_key=YOUR_API_KEY